AmCad BioMed, a Taiwan-based listed company (ticker: 4188),and a subsidiary under Maywufa Healthcare Group of Taiwan, develops artificial intelligence (AI) software to interpret ultrasound images. The FDA (510K) has cleared three patented deep learning innovation that spot thyroid nodule maliganancy and make upper airway for OSA assessment.
